Prior to the legalization of recreational cannabis throughout Canada, Health Canada is anticipating the demand for pot to be much higher than original predictions. A report by the government agency utilized a federal survey from 2017, on marijuana use, in attempt to measure just about how much pot adults will consume during first year of legalization.
The calculated amounted came to just under 930,000 kilograms, for both recreational and medicinal use, which is 41% higher than the previous estimate of 655,000 kilograms by the Parliamentary Budget Officer in 2016. If the findings of Health Canada’s new report deem to be true, our neighbor to the north could actually see a shortage in supplies with recreational legalization commencing next week. With expected demand outpacing supply, many investors are watching marijuana stocks this month.
Leafbuyer Technologies, Inc. (LBUY) is a comprehensive online source for cannabis deals and information that works alongside cannabis businesses to showcase their products to millions across it network. The company is the official cannabis deals platform of LA Weekly, Voice Media Group and Dope Media.
The company recently announced quarterly sales results rose 67% in the period ending September 30th, 2018, compared to the same period the previous year.
“We recently reported our FY sales results that ended on June 30th with a 42% growth rate. This recent quarter significantly increased that acceleration. The average monthly spend per customer is steadily increasing and we are seeing higher demand for our products in all of the legal states we cover,” said Leafbuyer Chairman and CEO, Kurt Rossner.
Cronos Group (CRON) (CRON.TO) is a globally diversified and vertically integrated cannabis company with a presence across five continents that operates two wholly-owned Canadian ACMPR-licensed producers: Peace Naturals Project Inc and Original BC Ltd.
Recently, Cronos Group and Aleafia Health Inc. (ALEAF) (ALEF) announced entering into a joint medical cannabis study to improve the management and treatment of insomnia and daytime sleepiness.
“Aleafia is excited to participate in a study with Cronos Group, a company with a firm commitment to patient health. For far too long, the answer to a patient’s sleeping disorder or chronic pain has been a prescription and a bottle of pills,” said Aleafia CMO Dr. Michael Verbora. “There is mounting evidence of the risks of prescription sleeping aids including worsening mental health and increased risk of dementia. This study may in part point to medical cannabis as an alternative to harmful prescription drugs.”
Liberty Health Sciences (LHSIF) (LHS) is a provider of trusted, high quality cannabis experiences. The company recently announced entering an exclusive partnership with AdaViv Inc., a hardware-enabled, predictive agriculture company, to improve production of cannabis at its Liberty Health Sciences 360 Innovation Campus in Gainesville, FL.
AdaViv’s technology enables 24/7 plant-level inspection as well as AI computer vision to uncover hidden plant biometrics that translates data into actionable insights for growers like Liberty.
“This partnership demonstrates Liberty’s commitment for being a cutting-edge company that consistently looks for new ways to advance common practices through data and technology,” said George Scorsis, CEO. “Working together, we hope to refine AdaViv’s game changing data capture and growth analytics technology to help us achieve the highest quality, consistency and yield for our crops, as well as monitor our plants in ways that our eyes never could. AdaViv will provide us with actionable knowledge, backed by real-time data. This will not only increase our output, but it will also boost our quality in a data driven format.”
Pursuant to an agreement between an affiliate of MAPH Enterprises, LLC (owners of MarijuanaStocks.com), Midam Ventures LLC and Leafbuyer Technologies Inc., Midam is being paid $50,000 for a period of 30 days beginning September 24, 2018 and ending October 24, 2018. We own 77,000 shares of Leafbuyer Technologies. We may buy or sell additional shares of (LBUY) in the open market at any time, including before, during or after the Website and Information, to provide public dissemination of favorable Information about Leafbuyer Technologies Inc.